Recombinant Danio rerio Heme transporter hrg1-B (slc48a1a)

What is the molecular function of Slc48a1a in zebrafish?

Slc48a1a (also known as Heme transporter hrg1-B) functions as a transmembrane protein that mediates the transport of heme from the phagolysosome into the cytosol during erythrophagocytosis. This protein plays a crucial role in iron homeostasis by enabling the recycling of heme-iron from senescent erythrocytes.

The molecular mechanism involves:

• Recognition and binding of heme molecules within the lysosomal compartment

• Conformational changes in the transmembrane domains

• Translocation of heme across the lysosomal membrane

• Release of heme into the cytoplasm for further processing

This transport function is essential for macrophages in the reticuloendothelial system (RES) to recycle iron from degraded erythrocytes . Without functional Slc48a1a, heme accumulates within lysosomes and can form crystalline structures known as hemozoin .

What is the structure and topology of the Slc48a1a protein?

The Slc48a1a protein from Danio rerio has the following structural characteristics:

• Protein length: 144 amino acids

• Complete amino acid sequence: MGPNRIYISVGYSTFGMLVGFSAFIVWNVVYKQPWTAAMGGLSGVLALWALVTHIMYIQDYWRTWLKGLKFFMFVSSVFSLLAVAAFATFITLSVIEKQSLSDPKSFYLSAVWSFMTLKWAFLLGLYSYRYRQEFADISILSDF

• Four predicted membrane-spanning domains

• N-terminal His tag in recombinant versions

The membrane topology is critical for its function, with transmembrane domains creating a channel for heme transport. The protein's structure enables it to shuttle heme across the lysosomal membrane while preventing the release of potentially toxic free heme into the cellular environment .

How is Slc48a1a related to mammalian SLC48A1?

Slc48a1a in zebrafish is orthologous to mammalian SLC48A1 (HRG1), showing significant functional and structural conservation:

The evolutionary conservation of this protein highlights its fundamental importance in heme trafficking and iron homeostasis across vertebrate species . Research in zebrafish models has direct relevance to understanding the human ortholog's function.

What are the synonyms and database identifiers for Slc48a1a?

When searching literature and databases, researchers should be aware of the various names and identifiers used for this protein:

• Gene symbols: slc48a1a, hrg1b, si:ch211-226m16.1, zgc:92662

• Protein names: Heme transporter hrg1-B, Heme-responsive gene 1 protein homolog B, HRG-1B, Solute carrier family 48 member 1-A

• UniProt ID: Q6ZM28

• Full nomenclature: Solute carrier family 48 (heme transporter), member 1A

These identifiers are essential for comprehensive literature searches and database queries when conducting research on this protein .

What are the optimal conditions for expressing recombinant Slc48a1a protein?

Based on successful expression protocols, the following conditions are recommended for producing recombinant Slc48a1a:

• Expression system: E. coli has been successfully used for full-length protein expression

• Tag configuration: N-terminal His-tag facilitates purification without compromising function

• Purification yield: Protocols typically achieve >90% purity as determined by SDS-PAGE

• Storage buffer: Tris/PBS-based buffer containing 6% Trehalose, pH 8.0

• Storage conditions: Store lyophilized powder at -20°C/-80°C

• Reconstitution: Reconstitute in deionized sterile water to 0.1-1.0 mg/mL

• Long-term storage: Add 5-50% glycerol (final concentration) and store in aliquots at -20°C/-80°C

• Stability considerations: Avoid repeated freeze-thaw cycles; working aliquots may be stored at 4°C for up to one week

These conditions maintain protein stability while preserving the native conformation necessary for functional studies .

What approaches can be used to generate Slc48a1a knockout models in zebrafish?

CRISPR-Cas9 gene editing has proven highly effective for generating Slc48a1a knockout models:

Recommended CRISPR guide design strategy:

• Target the region encoding the first transmembrane domain for higher likelihood of loss-of-function mutations

• Example guide RNA sequence that has shown success: 5′ TAGGGACGGTGGTCTACCGACAACCGG 3′

• Injection concentration: 5 ng/μl guide RNA combined with 5 ng/μl Cas9 RNA in 10 mM Tris, 0.25 mM EDTA (pH 7.5)

• Injection method: Standard pronuclear injection into fertilized eggs

Efficiency metrics:

• Expected efficiency: Approximately 41-47% of founder animals typically show edits in the Slc48a1a locus

• Mutation spectrum: Both frameshift and in-frame deletions can be generated

• Validation methods: Western blotting of spleen and liver tissue and mRNA analysis to confirm protein absence

This approach has been successfully used to create viable knockout models that exhibit specific phenotypes related to iron metabolism disruption .

How can researchers effectively measure Slc48a1a-mediated heme transport activity?

Several methodological approaches have been validated for assessing Slc48a1a transport activity:

In cellular models:

• Reporter systems: Use of Golgi-confined hemoprotein reporters such as horseradish peroxidase (HRP) to measure heme availability in the cytosol

• Transcriptional response: Quantification of heme-responsive genes like Hmox1, Ftn, and Fpn as indirect indicators of heme transport activity

• Iron chelation controls: Include desferroxamine treatments to distinguish heme-specific effects from general iron effects

In animal models:

• Tissue analysis: Detection of hemozoin formation in reticuloendothelial system macrophages as evidence of defective heme transport

• Dietary iron manipulation: Monitor hematological parameters under varying dietary iron conditions (5-400 ppm) to assess heme-iron recycling capacity

• Erythrophagocytosis assays: Ex vivo assays using bone marrow-derived macrophages challenged with damaged erythrocytes

These methodologies provide complementary approaches for comprehensive assessment of transport function in different experimental systems .

What methods are available for analyzing Slc48a1a localization in cells?

Subcellular localization studies are critical for understanding Slc48a1a function. The following approaches have been successfully employed:

Immunolocalization techniques:

• Colocalization with endolysosomal markers (e.g., Lamp1) using fluorescent microscopy

• Tracking during erythrophagocytosis to observe recruitment to the erythrophagolysosome

Biochemical fractionation:

• Separation of cellular compartments to quantify protein distribution

• Western blotting of isolated fractions using anti-Slc48a1a antibodies

Live cell imaging:

• Fluorescently tagged Slc48a1a constructs for real-time visualization

• Colocalization with labeled heme substrates or compartment markers

These approaches have revealed that Slc48a1a specifically localizes to endolysosomal compartments under basal conditions and is recruited to the erythrophagolysosome during erythrophagocytosis .

How does Slc48a1a function in the context of iron recycling from erythrocytes?

Slc48a1a plays a crucial role in the iron recycling pathway within the reticuloendothelial system:

• Senescent erythrocytes are engulfed by RES macrophages

• Erythrocytes are degraded within phagolysosomes, releasing hemoglobin

• Hemoglobin is broken down, liberating heme

• Slc48a1a transports this heme from the phagolysosome to the cytoplasm

• Cytoplasmic heme oxygenase converts heme to iron, carbon monoxide, and biliverdin

• Released iron is either stored in ferritin or exported via ferroportin

Disruption of this pathway in Slc48a1a-deficient models results in heme accumulation within macrophage lysosomes, ultimately leading to hemozoin crystal formation . This process becomes particularly evident at approximately 8 days of age in mouse models, which correlates with the onset of erythrocyte recycling .

What is the relationship between Slc48a1a deficiency and hemozoin formation?

A remarkable finding in Slc48a1a-deficient animal models is the formation of hemozoin crystals in reticuloendothelial system macrophages:

Mechanistic relationship:

• In normal macrophages, Slc48a1a transports heme from phagolysosomes to cytoplasm

• In Slc48a1a-deficient macrophages, heme accumulates within phagolysosomes

• To avoid heme toxicity, the accumulated heme crystallizes into hemozoin, a supposedly inert form

• This crystallization appears to be a protective mechanism against heme-induced damage

Analytical methods for hemozoin detection:

• Chemical extraction followed by high-resolution X-ray powder diffraction

• Comparison to malarial hemozoin standards for identification

• Immunohistochemistry, flow cytometry, and electron microscopy for localization

This phenomenon is particularly significant as hemozoin formation was previously thought to occur only in blood-feeding parasites such as Plasmodium, making Slc48a1a-deficient models a unique tool for studying this process in vertebrates .

How do dietary iron conditions affect phenotypes in Slc48a1a-deficient models?

The interaction between Slc48a1a deficiency and dietary iron intake produces distinct phenotypic outcomes:

These data demonstrate that Slc48a1a-deficient animals can maintain erythropoiesis when dietary iron is abundant but develop progressive anemia when dietary iron is restricted . The phenotype becomes significant after approximately 45 days on low-iron diets, corresponding to the turnover time for erythrocytes present at weaning .

This relationship suggests that Slc48a1a-mediated iron recycling becomes increasingly critical when dietary iron is limited, highlighting the protein's essential role in iron conservation .

What is the role of Slc48a1a in macrophage function during erythrophagocytosis?

Slc48a1a demonstrates specific regulatory and functional patterns in macrophages during erythrophagocytosis (EP):

Expression regulation:

• Slc48a1a is expressed in reticuloendothelial system macrophages under basal conditions

• Expression is upregulated both transcriptionally and at the protein level in response to:

  • Heme treatment

  • Iron exposure

  • During active erythrophagocytosis

• This upregulation occurs in both cultured bone marrow-derived macrophages and in vivo in the spleens and livers of animals exposed to heme, damaged RBCs, or hemolysis agents

Functional significance:

• During EP, Slc48a1a specifically localizes to the erythrophagolysosome membrane

• It mediates the critical step of transporting heme from this compartment to the cytosol

• This transport function enables appropriate transcriptional responses to heme accumulation, including upregulation of Hmox1, Ftn, and Fpn

• When Slc48a1a is depleted, macrophages cannot properly upregulate this transcriptional response, indicating defective heme processing

These findings position Slc48a1a as a key regulator of macrophage heme handling during erythrophagocytosis, with implications for both normal iron homeostasis and pathological conditions .

What human diseases might be associated with SLC48A1 deficiency or mutations?

While direct human disease associations with SLC48A1 variants are still emerging, research suggests several potential clinical relevance areas:

In regions with iron-poor diets:

• Idiopathic anemia could potentially be caused by SLC48A1 variants that impair heme-iron recycling

• The impact would be most significant in populations with limited dietary iron access

In regions with adequate dietary iron:

• SLC48A1 variants might lead to iron loading in RES macrophages

• This pattern resembles conditions such as Bantu siderosis or African Iron Overload (AIO)

• Iron accumulation could potentially contribute to inflammatory and oxidative stress pathways

Observed genetic evidence:

• A P36L polymorphism in human HRG1/SLC48A1 has been associated with anemia and defective heme transport in a small percentage of African Americans

• This variant showed impaired function when tested in:

  • Yeast heterologous systems

  • Zebrafish morphant rescue experiments

  • Bone marrow-derived macrophage functional assays

These translational insights suggest that SLC48A1 should be considered as a candidate gene in unresolved cases of iron metabolism disorders, particularly those with tissue-specific iron distribution abnormalities .

How can zebrafish Slc48a1a models contribute to therapeutic development for iron-related diseases?

Zebrafish Slc48a1a models offer several advantages for therapeutic discovery and validation:

High-throughput screening applications:

• Transparency of zebrafish embryos allows visualization of iron/heme distribution

• Ability to generate large numbers of genetically modified embryos

• Compatibility with automated phenotypic screening platforms

• Feasibility of chemical compound library screening in vivo

Therapeutic validation strategies:

• Testing gene therapy approaches for SLC48A1 replacement

• Screening for compounds that bypass defective heme transport

• Identifying modulators of alternative iron recycling pathways

• Evaluating interventions that prevent hemozoin formation

Comparative analysis value:

• Cross-species validation of gene function helps establish evolutionary conservation

• The P36L polymorphism in human SLC48A1 has been successfully studied using zebrafish morphants

• Phenotypic rescue experiments can validate the functional significance of human variants

These applications make zebrafish Slc48a1a models valuable translational tools that bridge basic research and therapeutic development for iron homeostasis disorders .

What experimental approaches can resolve contradictory findings in Slc48a1a research?

When researchers encounter seemingly contradictory results in Slc48a1a studies, several methodological approaches can help resolve these discrepancies:

Controlled dietary conditions:

• Standardize iron content in diets (5-400 ppm range has shown distinct phenotypes)

• Account for maternal dietary effects in developing animals

• Monitor dietary intake to ensure consistent dosing

Genetic background considerations:

• Back-cross mutant lines to standard backgrounds (minimum 4 generations)

• Use littermate controls whenever possible

• Report complete genetic backgrounds in publications

Age-dependent phenotyping:

• Assess phenotypes at standardized developmental timepoints

• Note that hemozoin first appears at 8 days in mouse models

• Consider erythrocyte lifespan (~45 days in mice) when evaluating anemia progression

Tissue-specific analyses:

• Separately analyze effects in different iron-handling tissues (spleen, liver, bone marrow)

• Account for ~15% spleen size increase in Slc48a1a-deficient animals

• Distinguish systemic from tissue-specific phenotypes

These methodological considerations are crucial for generating reproducible and comparable results across different research groups investigating Slc48a1a function .

What is the evolutionary significance of Slc48a1a/HRG1 conservation across species?

The evolutionary conservation of HRG1/Slc48a1a across diverse species provides important insights into iron homeostasis:

Phylogenetic distribution:

• Originally discovered in Caenorhabditis elegans

• Functional orthologs identified in:

  • Yeast models (heterologous expression)

  • Zebrafish (Slc48a1a)

  • Mice and humans (SLC48A1)

Functional conservation:

• Heme transport function is maintained across evolutionarily distant species

• Conserved topology with four membrane-spanning domains

• Similar subcellular localization to endolysosomal compartments

Evolutionary adaptations:

• In blood-feeding parasites like Plasmodium, hemozoin formation evolved as a detoxification strategy

• In vertebrates, hemozoin formation emerges only in pathological states (Slc48a1a deficiency)

• This convergent evolution suggests fundamental constraints in heme handling biology

The deep evolutionary conservation of this transport system highlights the ancient origins of heme-iron recycling mechanisms and their fundamental importance in cellular metabolism across the eukaryotic domain .